Bayesian Capital Management’s iPath Series B S&P 500 VIX Short-Term Futures ETN VXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-613
Closed -$593K 1000
2019
Q4
$593K Sell
613
-564
-48% -$683K 0.1% 274
2019
Q3
$1.79M Buy
+1,177
New +$1.87M 0.34% 73

Other funds holding VXX

Bayesian Capital Management's VXX Position: Q1 2020 in Review

Bayesian Capital Management sold out of iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX) in Q1 2020, closing a stake of 613 shares — an estimated $593K sold.

Bayesian Capital Management first reported a position in VXX in Q3 2019 and held it in 2 quarters. The position peaked at $1.79M in Q3 2019. 67 funds tracked by Wall St. Rank hold VXX as of Q1 2020.

  • Bayesian Capital Management reported no remaining iPath Series B S&P 500 VIX Short-Term Futures ETN position as of Q1 2020 after selling out during the quarter.
  • Bayesian Capital Management sold 613 iPath Series B S&P 500 VIX Short-Term Futures ETN shares in Q1 2020, an estimated $593K.
  • Bayesian Capital Management first reported a position in iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019 and held it in 2 quarters.
  • Bayesian Capital Management's iPath Series B S&P 500 VIX Short-Term Futures ETN position peaked at $1.79M in Q3 2019.
  • 67 funds tracked by Wall St. Rank held iPath Series B S&P 500 VIX Short-Term Futures ETN as of Q1 2020.

Based on Bayesian Capital Management's 13F filing for Q1 2020, filed 15 May 2020.